May 9 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.61 4.26 5.00 2.50
(+8.4 pct) (-7.6 pct) (+8.3 pct) (+7.3 pct)
Operating 747 mln 632 mln 800 mln 400 mln
(+18.3 pct) (+3.9 pct) (+7.0 pct) (-9.5 pct)
Recurring 777 mln 653 mln 800 mln 400 mln
(+19.0 pct) (+6.1 pct) (+2.8 pct) (-9.9 pct)
Net 512 mln 417 mln 520 mln 260 mln
(+22.7 pct) (+4.7 pct) (+1.5 pct) (-13.7 pct)
EPS 126.39 yen 100.63 yen 128.28 yen 64.14 yen
Ann Div 25.00 yen 15.00 yen 25.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 25.00 yen 15.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T